RNA结合蛋白广泛调控人类心脏纤维化的翻译过程
该研究利用RNA测序和核糖体图谱监测人心脏成纤维细胞活化过程中RNA转录和翻译的全基因组变化,发现约三分之一的基因表达变化受翻译调控,且RNA结合蛋白PUM2和QKI等构成调控网络,在扩张型心肌病患者心脏中同样活跃,沉默这些枢纽基因可抑制成纤维细胞向肌成纤维细胞转化。
要点
- 约三分之一的基因表达变化受翻译调控,核糖体占据动态影响蛋白丰度。
- RNA结合蛋白如PUM2和QKI协同调控靶转录本的翻译。
- 沉默PUM2和QKI可抑制TGF-β1诱导的成纤维细胞活化。
核心结论
- TGF-β1驱动的心脏成纤维细胞向肌成纤维细胞转化涉及广泛的翻译调控,新发现的转录后调控网络在人类心脏疾病中活跃,沉默枢纽基因可限制成纤维细胞活化。
研究设计与样本
- 研究对人心脏成纤维细胞活化过程进行RNA测序和核糖体图谱分析,并整合30例扩张型心肌病患者的心脏核糖体占据水平数据。
主要发现
- 在TGF-β1驱动的细胞转化过程中,约三分之一的基因表达变化受翻译调控,核糖体占据动态变化独立于RNA水平影响蛋白丰度。
- RNA结合蛋白的靶基因在转录后调控基因中富集,提示MBNL2等可作为翻译激活或抑制因子。
- 扩张型心肌病患者心脏的核糖体占据提示相同的转录后调控网络参与心脏纤维化,关键枢纽包括PUM2和QKI。
- 沉默PUM2和QKI可抑制TGF-β1诱导的成纤维细胞向促纤维化肌成纤维细胞转化。
临床怎么用
- 针对PUM2和QKI等翻译调控枢纽可能为抑制心脏纤维化提供新策略。
- 评估心脏纤维化时需考虑翻译调控对蛋白丰度的影响,而不仅关注RNA水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fibrosis is a common pathology in many cardiac disorders and is driven by the activation of resident fibroblasts. The global posttranscriptional mechanisms underlying fibroblast-to-myofibroblast conversion in the heart have not been explored. METHODS: Genome-wide changes of RNA transcription and translation during human cardiac fibroblast activation were monitored with RNA sequencing and ribosome profiling. We then used RNA-binding protein-based analyses to identify translational regulators of fibrogenic genes. The integration with cardiac ribosome occupancy levels of 30 dilated cardiomyopathy patients demonstrates that these posttranscriptional mechanisms are also active in the diseased fibrotic human heart. RESULTS: We generated nucleotide-resolution translatome data during the transforming growth factor β1-driven cellular transition of human cardiac fibroblasts to myofibroblasts. This identified dynamic changes of RNA transcription and translation at several time points during the fibrotic response, revealing transient and early-responder genes. Remarkably, about one-third of all changes in gene expression in activated fibroblasts are subject to translational regulation, and dynamic variation in ribosome occupancy affects protein abundance independent of RNA levels. Targets of RNA-binding proteins were strongly enriched in posttranscriptionally regulated genes, suggesting genes such as MBNL2 can act as translational activators or repressors. Ribosome occupancy in the hearts of patients with dilated cardiomyopathy suggested the same posttranscriptional regulatory network was underlying cardiac fibrosis. Key network hubs include RNA-binding proteins such as Pumilio RNA binding family member 2 (PUM2) and Quaking (QKI) that work in concert to regulate the translation of target transcripts in human diseased hearts. Furthermore, silencing of both PUM2 and QKI inhibits the transition of fibroblasts toward profibrotic myofibroblasts in response to transforming growth factor β1. CONCLUSIONS: We reveal widespread translational effects of transforming growth factor β1 and define novel posttranscriptional regulatory networks that control the fibroblast-to-myofibroblast transition. These networks are active in human heart disease, and silencing of hub genes limits fibroblast activation. Our findings show the central importance of translational control in fibrosis and highlight novel pathogenic mechanisms in heart failure.
引用
- Chothani S, Schäfer S, Adami E, et al. Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins. Circulation. 2019. PMID: 31284728. doi:10.1161/CIRCULATIONAHA.119.039596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。